News Daily News LDL Cholesterol Control Post-PCI Is Low and Linked to Worse Outcomes Yael L. Maxwell September 14, 2020
News Conference News TVT 2020 Antithrombotics After PFO Closure: Much to Discuss, Little Data to Inform Yael L. Maxwell June 26, 2020
News Daily News Type 2 MI Linked to More CV Deaths, Even in Younger Patients Shelley Wood March 04, 2020
News Conference News EuroPCR 2019 Long-term Ticagrelor Monotherapy May Have an Edge in Complex PCI Patients: GLOBAL LEADERS Michael O'Riordan May 21, 2019
News Conference News ACC 2019 Modest LDL Cholesterol Reduction With Bempedoic Acid in Among High-Risk Patients: CLEAR Wisdom Michael O'Riordan March 20, 2019
News Daily News Most Cardiovascular Drugs Can Be Safely Used in Pregnancy, Review Suggests Todd Neale February 01, 2019
News Conference News AHA 2018 Rivaroxaban Lowers Thromboembolic Risk in HF Patients: COMMANDER HF Todd Neale November 11, 2018
News Daily News Post-MI Beta-blocker Use Dropped During Metoprolol ER Shortage, but Outcomes Unaffected Todd Neale October 15, 2018
News Daily News Platelet Reactivity Linked With Ischemic Stroke Risk Post-DES Implantation: ADAPT-DES Substudy Yael L. Maxwell June 08, 2018
News Daily News ESC Consensus Statement Tackles Inflammation, Cholesterol Connection in a Post-CANTOS World Caitlin E. Cox May 16, 2018
News Conference News ACC 2018 ACC 2018, Day Three: Gout, Hypertension, Diabetes, PFO Closure, DAPT, NOAC Reversal, and More Shelley Wood March 12, 2018
News Conference News ESC 2017 CANTOS: Anti-inflammatory Agent Canakinumab Modestly Reduces Major CVD Events Michael O'Riordan August 27, 2017
News Daily News Current NSAID Use Linked to Increased Risk of Heart Failure, Large European Analysis Shows Michael O'Riordan September 30, 2016
News Daily News Review Touts Benefits of Statins, Seeks to Dispel Safety Concerns Todd Neale September 12, 2016
News Daily News Data Support Treating Patient Risk, Not LDL Cholesterol Targets, Paper Argues Michael O'Riordan February 15, 2016
News Daily News AIDA STEMI Substudy Confirms No Advantage for Intracoronary Abciximab February 27, 2013